Pacemaker with automatic blanking period function

• US 5,591,214 A
• Filed: 11/20/1995
• Issued: 01/07/1997
• Est. Priority Date: 11/20/1995
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories Incorporated)
• Inventors: Lu, Richard
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): Getzow, Scott M.
• Application Number:
  US08/560,733
• Time in Patent Office: 414 Days
• Field of Search: 607/4, 607/9, 607/27, 607/28, 607/11
• US Class Current: 607/9
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control

Abstract

The blanking periods for an implantable cardiac device, such as a pacemaker, is determined by providing an excitation in a cardiac chamber and monitoring the corresponding cardiac activity. For in-channel blanking periods, the response from the same chamber is monitored while for cross-channel blanking period, the other cardiac chamber is monitored. The optimal blanking period is then determined based on the cardiac activity. This period is programmed directly into the device, or transmitted to an external programmer where it is used to provide guidance to a health care professional. The optimal blanking period duration may also be determined using other signals sensed by the programmer, using ECG'"'"'s or MTE'"'"'s.

Claims

1. A cardiac stimulation system comprising:

pacing means for generating cardiac pacing signals of a patient;

sensing means for sensing cardiac activity in a cardiac chamber, said sensing means generating sense signals corresponding said cardiac activity;

signal processing means for processing said sense signals;

blanking signal generating means for generating blanking signals, said blanking signals being provided for selectively blanking said signal processing means; and

automatic blanking determining means for determining a minimum duration of said blanking signals dependent on physiological characteristics of said heart wherein said automatic blanking determining means includes means for generating a test pacing signal for said heart and test sensing means for sensing activity in said heart responsive to said test pacing signal.

2. The system of claim 1 further comprising an implantable cardiac device, said automatic blanking determining means being disposed in said implantable cardiac device.

3. The system of claim 1 wherein said automatic blanking determining means includes amplitude sensing means for measuring a period from said test pacing signal until said cardiac activity falls below a threshold, said determining means selecting a first blanking signal based on said period.

4. The system of claim 3 wherein said test pacing signal is delivered in a first cardiac chamber and said activity is sensed in a second cardiac chamber to determine a first cross-channel blanking signal.

5. The system of claim 3 wherein said test pacing signal is delivered in a first cardiac chamber and said activity is sensed in said first cardiac chamber to determine a first in-channel blanking period.

6. An implantable cardiac device for implantation in a patient for stimulating the patient'"'"'s heart, comprising:

pacing means for generating pacing pulses for a first cardiac chamber;

sensing means for sensing cardiac activity in said heart;

blanking means for blanking said sensing means for at least a blanking period following said cardiac activity;

determining means for determining a duration of said blanking period based on a physiology of said heart, wherein said determining means generates a test signal in said first chamber, measures a response to said test signal and determines said duration in accordance with said response.

7. The device of claim 6 wherein said determining means measures said response in said first chamber to determine an in-channel blanking period.

8. The device of claim 7 wherein said first chamber is the atrium.

9. The device of claim 7 wherein said first chamber is the ventricle.

10. The device of claim 6 wherein said determining means measures said response in a second chamber to determine a cross channel blanking period.

11. The device of claim 6 wherein said determining means includes detecting means for detecting a peak of said activity.

12. The device of claim 11 wherein said duration extends from said test signal to a time when said peak falls below a threshold.

13. The device of claim 12 wherein said threshold is a fraction of a maximum peak of said activity.

14. The device of claim 6 wherein said blanking period is set by incrementing said duration a preselected safety margin.

15. The device of claim 14 wherein said safety margin is about 10-30 ms.

16. The device of claim 14 wherein said blanking period is limited to a preselected maximum value.

17. The device of claim 6 wherein said duration is provided to an external programmer used to program said device.